Evaluation of anticoagulation and nonsurgical major bleeding in recipients of continuous‐flow left ventricular assist devices

Continuous‐flow left ventricular assist device (LVAD) placement has become a standard of care in advanced heart failure treatment. Bleeding is the most frequently reported adverse event after LVAD implantation and may be increased by antithrombotic agents used for prevention of pump thrombosis. This...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Artificial organs Jg. 43; H. 8; S. 736 - 744
Hauptverfasser:	Veasey, Tara M., Floroff, Catherine K., Strout, Sara E., McElray, Krista L., Brisco‐Bacik, Meredith A., Cook, Jennifer L., Toole, John M., Craig, Michael L., Van Bakel, Adrian B., Meadows, Holly B., Uber, Walter E.
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States Wiley Subscription Services, Inc 01.08.2019
Schlagworte:	Aged Anticoagulants Anticoagulants - adverse effects Anticoagulants - therapeutic use anticoagulation Bleeding Blood Coagulation - drug effects Congestive heart failure Erythrocytes Female Heart Heart-Assist Devices - adverse effects Hemoglobin Hemorrhage Hemorrhage - etiology Hemorrhage - therapy Humans Implantation Incidence Intracranial Hemorrhages - etiology Intracranial Hemorrhages - therapy left ventricular assist device LVAD Male Middle Aged Renal function Retrospective Studies Thromboembolism Thrombosis Thrombosis - prevention & control Ventricle Ventricular assist devices bleeding left ventricular assist device LVAD anticoagulation
ISSN:	0160-564X, 1525-1594, 1525-1594
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!